Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04104672
Title A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arcus Biosciences, Inc.
Indications

pancreatic adenocarcinoma

Therapies

AB680 + Zimberelimab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.